These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6156529)

  • 21. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolongation of kidney allograft survival in dogs with donor pretreatment.
    Chassot PG; Beaudoin JG; Guttmann RD
    Surg Forum; 1974; 25(0):314-6. PubMed ID: 4612787
    [No Abstract]   [Full Text] [Related]  

  • 24. The interaction of cyclosporin A with other immunosuppressive agents in dog recipients of renal allografts.
    Homan WP; French ME; Fabre JW; Millard PR; Denton TG; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):287-90. PubMed ID: 6994297
    [No Abstract]   [Full Text] [Related]  

  • 25. Active enhancement of canine liver allografts--effect of pretreatment with prednisolone and donor-specific antigen.
    Lie TS; Nakano H; Bumanowski W; Rommelsheim K
    Surgery; 1976 Nov; 80(5):565-8. PubMed ID: 62410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The survival of renal allografts in dogs treated with immunosuppressive drugs.
    Rappel R
    J Am Osteopath Assoc; 1967 Jun; 66(10):1133-40. PubMed ID: 4167311
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro alteration of canine renal allografts with cyclophosphamide metabolites.
    Zincke H; Jardine I; Colvin M; Aydin G; Okiye SE
    Transplant Proc; 1983 Jun; 15(2):1698-701. PubMed ID: 6349051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine.
    Toledo-Pereyra LH; Simmons RL; Olson LC; Najarian JS
    Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
    Sterioff S; Zincke H; Waltzer WC; Moore SB; Frohnert PP; Offord KP
    Arch Surg; 1981 Jan; 116(1):73-7. PubMed ID: 7008743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG.
    Rowinski W; Ryffa T; Ruke M; Wasowska B; Tilney NL; Olszewski WL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):586-8. PubMed ID: 6168052
    [No Abstract]   [Full Text] [Related]  

  • 34. Donor pretreatment.
    Br Med J; 1977 Nov; 2(6096):1172. PubMed ID: 338098
    [No Abstract]   [Full Text] [Related]  

  • 35. Coagulation changes in sensitized canine renal allografts.
    Brennan TG; Giles GR; Rajah SM; Davison AM; Guillou PJ
    Br J Surg; 1977 Jan; 64(1):15-22. PubMed ID: 318883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts.
    Pratschke J; Paz D; Wilhelm MJ; Laskowski I; Kofla G; Vergopoulos A; MacKenzie HJ; Tullius SG; Neuhaus P; Hancock WW; Volk HD; Tilney NL
    Transplantation; 2004 Jan; 77(1):43-8. PubMed ID: 14724433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.
    Chatterjee SN; Smith R; Fine S; Schulman B; Fine RN
    Transplant Proc; 1981 Mar; 13(1 Pt 2):709-11. PubMed ID: 7022938
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats.
    Eto M; Nishimura Y; Matsuo K; Omoto K; Goto K; Kumuzawa J; Nomoto K
    J Urol; 1995 May; 153(5):1693-6. PubMed ID: 7715012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.